Skip to main content
AmigoFish

Clozapine Monitoring: New Guidelines for the Post-REMS Era

From Psychopharmacology and Psychiatry Updates · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety.

Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

- Learn more about our membership here

- Earn 0.75 CMEs: Quick Take Vol. 79

- New Guidelines for Clozapine ANC Monitoring

Back to Psychopharmacology and Psychiatry Updates · Report a problem